Your browser doesn't support javascript.
loading
Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias.
Zheng, Chao; Lin, Xisheng; Xu, Xiaolong; Wang, Cheng; Zhou, Jinru; Gao, Bo; Fan, Jing; Lu, Weiguang; Hu, Yaqian; Jie, Qiang; Luo, Zhuojing; Yang, Liu.
Afiliação
  • Zheng C; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Lin X; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Xu X; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Wang C; School of Biomedical Sciences, University of Hong Kong, Hong Kong, China.
  • Zhou J; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Gao B; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Fan J; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Lu W; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Hu Y; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Jie Q; Department of Orthopedic Surgery, HongHui Hospital, Xi'an Jiaotong University, College of Medicine, Xi'an, China.
  • Luo Z; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China; Medical Research Institute, Northwestern Polytechnical University, Xi'an, China.
  • Yang L; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China; Medical Research Institute, Northwestern Polytechnical University, Xi'an, China. Electronic address: yangliu@fmmu.edu.cn.
EBioMedicine ; 40: 695-709, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30685387
ABSTRACT

BACKGROUND:

Mutations in the SLC26A2 gene cause a spectrum of currently incurable human chondrodysplasias. However, genotype-phenotype relationships of SLC26A2-deficient chondrodysplasias are still perplexing and thus stunt therapeutic development.

METHODS:

To investigate the causative role of SLC26A2 deficiency in chondrodysplasias and confirm its skeleton-specific pathology, we generated and analyzed slc26a2-/- and Col2a1-Cre; slc26a2fl/fl mice. The therapeutic effect of NVP-BGJ398, an FGFR inhibitor, was tested with both explant cultures and timed pregnant females.

FINDINGS:

Two lethal forms of human SLC26A2-related chondrodysplasias, achondrogenesis type IB (ACG1B) and atelosteogenesis type II (AO2), are phenocopied by slc26a2-/- mice. Unexpectedly, slc26a2-/- chondrocytes are defective for collagen secretion, exhibiting intracellular retention and compromised extracellular deposition of ColII and ColIX. As a consequence, the ATF6 arm of the unfolded protein response (UPR) is preferentially triggered to overactivate FGFR3 signaling by inducing excessive FGFR3 in slc26a2-/- chondrocytes. Consistently, suppressing FGFR3 signaling by blocking either FGFR3 or phosphorylation of the downstream effector favors the recovery of slc26a2-/- cartilage cultures from impaired growth and unbalanced cell proliferation and apoptosis. Moreover, administration of an FGFR inhibitor to pregnant females shows therapeutic effects on pathological features in slc26a2-/- newborns. Finally, we confirm the skeleton-specific lethality and pathology of global SLC26A2 deletion through analyzing the Col2a1-Cre; slc26a2fl/fl mouse line.

INTERPRETATION:

Our study unveils a previously unrecognized pathogenic mechanism underlying ACG1B and AO2, and supports suppression of FGFR3 signaling as a promising therapeutic approach for SLC26A2-related chondrodysplasias. FUND This work was supported by National Natural Science Foundation of China (81871743, 81730065 and 81772377).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acondroplasia / Transdução de Sinais / Receptor Tipo 3 de Fator de Crescimento de Fibroblastos / Resposta a Proteínas não Dobradas / Transportadores de Sulfato Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acondroplasia / Transdução de Sinais / Receptor Tipo 3 de Fator de Crescimento de Fibroblastos / Resposta a Proteínas não Dobradas / Transportadores de Sulfato Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China